Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Helsinki-based Aiforia secures €20 million EIB financing to advance AI-powered cancer diagnostics. This venture debt financing will accelerate Aiforia’s product development and enhance commercial operations.
Aiforia has secured €20 million in venture debt financing from the European Investment Bank (EIB) to boost its product development and commercial operations. The financing is structured in three tranches, with the first tranche being €5 million. The agreement includes a synthetic warrant arrangement to avoid immediate share dilution. CEO Jukka Tapaninen noted that this financing strengthens Aiforia’s financial position and supports its strategic implementation.
Company Information
Company
Aiforia
Location
Helsinki, Uusimaa, Finland
About
Aiforia is a Helsinki-based life-science company providing deep learning AI solutions for pathology. Founded in 2013 as a spin-off from the University of Helsinki, it delivers software solutions that elevate diagnostic capabilities in image analysis. Aiforia equips pathologists and scientists with AI software for translating images into discoveries, decisions, and diagnoses. The company is publicly traded and operates internationally.
HelsinkiBiotechnologySoftwareArtificial IntelligenceMachine Learning